Metoprolol Teva (Metoprolol Tartrate)

Metoprolol tartrate is a selective β1‑adrenergic receptor antagonist. By blocking these receptors in the heart, it reduces the effects of adrenaline and noradrenaline, leading to a slower heart rate, decreased myocardial contractility, and lower cardiac output. This results in reduced blood pressure and oxygen demand by the heart muscle.

The appropriate dose of Metoprolol Teva is individualized by the prescribing clinician based on the specific indication, patient age, renal and hepatic function, and response to therapy. Dosage adjustments may be required for conditions such as heart failure or in patients with impaired organ function.

Safety data for metoprolol during pregnancy are limited, and the drug should only be used if the potential benefit justifies the potential risk to the fetus. It is excreted in breast milk, so caution is advised for nursing mothers, and a healthcare professional should evaluate the risk‑benefit balance.

To place an order, submit an enquiry on the Metoprolol Teva product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Metoprolol Teva is a cardio‑selective (β1‑selective) beta blocker, offering a lower risk of bronchospasm compared with non‑selective agents such as propranolol. It is commonly used for hypertension, angina and heart failure, whereas some other beta blockers may be preferred for migraine prophylaxis or essential tremor. Choice depends on the clinical scenario and patient tolerance.

Metoprolol Teva should be stored at room temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture, heat and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Metoprolol Teva is taken orally, usually with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing schedule provided by their healthcare professional and not alter the regimen without consultation.

Serious adverse events include severe bradycardia, heart block, marked hypotension, bronchospasm (especially in patients with asthma or COPD), and allergic reactions such as rash or angioedema. Patients should seek immediate medical attention if they experience fainting, extreme fatigue, difficulty breathing, or swelling of the face or throat.

Metoprolol Teva is contraindicated in patients with known hypersensitivity to metoprolol or any component of the formulation, those with severe bradycardia, second‑ or third‑degree heart block without a pacemaker, cardiogenic shock, or overt heart failure decompensation. Caution is also advised for individuals with severe asthma or chronic obstructive pulmonary disease.